ANALYSIS OF CLINICAL OUTCOMES BASED ON MOLECULAR SUBTYPES IN PATIENTS WITH BREAST CANCER THAT RECEIVED NEOADJUVANT CHEMOTHERAPY

Authors

  • Gustavo Nader Marta Instituto do Câncer do Estado de São Paulo
  • Max S. Mano Hospital Sírio-Libanês
  • Allan A. Lima Pereira Hospital Sírio-Libanês

DOI:

https://doi.org/10.29289/259453942019v29s1g03

Downloads

Download data is not yet available.

Author Biographies

Gustavo Nader Marta, Instituto do Câncer do Estado de São Paulo

Department of Radiation Oncology, Hospital Sírio-Libanês Department of Radiology and Oncology, Radiation Oncology Unit, School of Medicine, Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo

Max S. Mano, Hospital Sírio-Libanês

Department of Clinical Oncology, Hospital Sírio-Libanês

Downloads

Published

2019-09-29

How to Cite

Marta, G. N., Mano, M. S., & Pereira, A. A. L. (2019). ANALYSIS OF CLINICAL OUTCOMES BASED ON MOLECULAR SUBTYPES IN PATIENTS WITH BREAST CANCER THAT RECEIVED NEOADJUVANT CHEMOTHERAPY. Mastology, 29(3), 4. https://doi.org/10.29289/259453942019v29s1g03

Issue

Vol. 29 No. 3 (2019): Supplement 1

Section

Geral

License

Copyright (c) 2019 Gustavo Nader Marta, Max S. Mano, Allan A. Lima Pereira

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.